EBD Group is part of the KNect365 of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Partnerships in Cell and Gene Therapy Partnerships in Cell and Gene Therapy Partnerships in Cell and Gene Therapy Partnerships in Cell and Gene Therapy
Share/Follow Us
Share this:
Follow this event:
Subscribe to our newsletters:

Panelists and Advisors

Zami Aberman Zami Aberman
Chairman and CEO
Jörn  Aldag Jörn Aldag
uniQure N.V.
Daniel G.  Anderson Daniel G. Anderson
Associate Professor, Department of Chemical Engineering, Institute for Medical Engineering and Science, Harvard-MIT
Jette Asboe Lassen
Director of Business Development
Symphogen A/S
Philip Astley-Sparke Philip Astley-Sparke
President US,
Dolores Bakash
Innovation Leader, Cell Therapy Technologies
GE Healthcare Life Sciences
Elona Baum Elona Baum
General Counsel and VP, Business Development
Claudio Bordignon Claudio Bordignon
Chairman and CEO
MolMed S.p.A.
Frank Borriello Frank Borriello
VP, Head of Search and Evaluation, Global Business Development
Jean-Philippe Combal Jean-Philippe Combal
Chief Operating Officer
GenSight Biologics
Michel  Detheux Michel Detheux
Co-Founder and CEO
iTeos Therapeutics
Douglas Doerfler Douglas Doerfler
President and CEO
MaxCyte Inc.
Iain Dukes Iain Dukes
Senior VP, Business Development and Licensing
Chris Gemmiti Chris Gemmiti
Business Development Lead
Wyss Institute for Biologically Inspired Engineering Harvard Unversity
Beatrice Gerard Beatrice Gerard
VP, Advisory Services
Strategic Drug Development
Alexandra Glucksmann Alexandra Glucksmann
Chief Operating Officer
Editas Medicine
Jeff Goater Jeff Goater
Senior VP, Finance and Business Development
Voyager Therapeutics
Sarah Haecker Sarah Haecker
Chief Scientific Officer
Adjuvant Partners
Gunnar Kvalheim Gunnar Kvalheim
Head, Department of Cellular Therapy
Oslo University Hospital
Edward Lanphier Edward Lanphier
President and CEO
Sangamo BioSciences
Michael Leek Michael Leek
Chief Executive
TC BioPharm
Philippe Lopes-Fernandes Philippe Lopes-Fernandes
Senior VP and Head,
Global Business Development and Alliance Management
Sven Ante (Bill) Lundberg Sven Ante (Bill) Lundberg
Chief Scientific Officer
CRISPR Therapeutics
Christian Meyer Christian Meyer
Chief Medical Officer
Mohamed Ragab Mohamed Ragab
VP, Head, Oncology Search and Evaluation, Business Development
Bristol-Myers Squibb
Georges Rawadi Georges Rawadi
VP, Business Development
Brock Reeve Brock Reeve
Executive Director
Harvard Stem Cell Institute
Morrie Ruffin Morrie Ruffin
Managing Partner
Adjuvant Partners
Dolores J. Schendel Dolores J. Schendel
Chief Scientific Officer, Executive Board
Medigene AG
Gary M.  Sclar Gary M. Sclar
Associate Director
Dana-Farber Cancer Institute
Jason Slingsby Jason Slingsby
Head, Business Development
Oxford BioMedica
Mike  Ward Mike Ward
Global Director of Content
Informa Pharma Insights
Arrow Up

Follow this event:
Home | Contact Us | Site Map
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2016 EBD Group
Privacy Policy and Cookies
Terms of Use